Clinical Trials Directory

Trials / Completed

CompletedNCT05039528

Design and Usability Testing of a Tailored Intervention About Sleep and Sleep Disorders Among Transportation Workers

Design and Usability Testing of a Tailored Intervention to Increase Awareness About Sleep and Sleep Disorders Among Transportation Workers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The objective of this protocol is to conduct a focus group to identify OSA beliefs, attitudes, and knowledge among employees in the transportation industry on shift schedules.

Detailed description

Transportation shift workers (TSW, e.g., overnight, on-call, or rotating) have been identified as a high-risk group for health conditions (e.g., obesity, cardiovascular disease). Also, TSW are at risk for obstructive sleep apnea (OSA). According to one study, approximately 36% of TSWs have OSA, a condition that exacerbates health risks and daytime sleepiness. A recent report from the American Academy of Sleep Medicine (AASM) showed that those with untreated OSA cost on average $4,261 more than those without OSA. Also concerning, workers with OSA who are non-adherent to recommended OSA treatment (i.e., continuous positive airway pressure, CPAP) are at particularly high risk for motor vehicle accidents compared to those who are adherent. This protocol outlines focus groups that will aim to identify knowledge, attitudes, and beliefs about OSA among TSW. Results of these focus groups will be used in future research to design a tailored website for relaying OSA information to TSW.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPersonalized OSA messagesParticipants will receive personalized OSA messages designed to nudge and navigate them toward evaluation and treatment for OSA. Participants will complete questionnaires at baseline and at study follow-up.
OTHERControlParticipants will complete questionnaires at baseline and at study follow-up. At the end of the study period, participants will receive the OSA message intervention.

Timeline

Start date
2022-10-01
Primary completion
2024-07-01
Completion
2024-07-01
First posted
2021-09-09
Last updated
2024-07-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05039528. Inclusion in this directory is not an endorsement.